Publication | Closed Access
Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
38
Citations
18
References
2018
Year
Pretreated PatientsOncologyReal-life EfficacyPathologyBronchial NeoplasmCancer TreatmentCancer GeneticsMedicineEgfr T790m MutationLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1